GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs
Original Report
Justin Schrieber, CEO of telehealth company LifeMD, said that the main reason that Americans end up at virtual health care providers is to access GLP-1 weight loss medication, as well as other...
Justin Schrieber, CEO of telehealth company LifeMD, said that the main reason that Americans end up at virtual health care providers is to access GLP-1 weight loss medication, as well as other prescription medication. Schreiber said that there is still an untapped market for GLP-1 access and the next frontier of virtual access is for hormone replacement care. (Source: Bloomberg)
Glass House Analysis
Corporate decisions reverberate through local communities—a merger might mean headquarters relocating, a restructuring could eliminate jobs, and strategic shifts affect suppliers and service providers in countless towns. Behind quarterly earnings numbers are real employment decisions, investment choices, and community impacts that shape the economic landscape of regions across the country.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Kentucky Republican Thomas Massie is Trump revenge tour's next target
Rep. Thomas Massie will face off on Tuesday against a Trump-backed candidate in a Republican primary in Kentucky's 4th congressional district.
3 men have been killed at a San Diego mosque and both suspects are dead, police say
Three men were killed in a shooting at a San Diego mosque Monday and both suspects are dead, police said.
Musk slams Altman trial verdict as a 'technicality,' vows to appeal
A jury in Oakland, California, ruled against Elon Musk in his dramatic court battle with Sam Altman and OpenAI.
The S&P 500 and most of its stocks are heading in opposite directions at a record pace. What investors should know.
Here are the S&P 500’s top gainers in market value this year and this quarter